Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Renaissance Capital Greenwich Fund (NY: IPOS)
21.62 USD  +0.04 (+0.16%)
Official Closing Price  /  Updated: 8:00 PM EDT, Jul 15, 2019  /  Add to My Watchlist      
View: Quote News
Fund Overview
Renaissance Capital Greenwich Fund
Sector
Exchange Traded NY
Net Assets 2.16M
Inception Date
Related Funds
Quote
Price 21.62
Volume 800
Last Trade Jul 15, 8:00pm
Change (%)
+0.04 (0.16%)
Prev. Close 21.59
YTD %
+15.46%
Dividend Yield 0.97%
Performance
YTD
+2.89 (15.46%)
1 Month
+0.61 (2.88%)
3 Month
-0.11 (-0.53%)
6 Month
+2.43 (12.63%)
1 Year
-0.95 (-4.19%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
IPO Expert On AB InBev's Canceled Go-Public Plan: It Wasn't Clear From Day One
Beer giant Anheuser Busch Inbev NV (NYSE: BUD) will no longer proceed with the planned IPO of its Asian unit due to "several ... Read More
from Benzinga
Genmab IPO: What You Need To Know
An OTC-listed large-cap biotech is seeking a main exchange listing, and it offers scope for investing in a proven biotech with two ... Read More
from Benzinga
Top News
More News
IPO Outlook For The Week: Biotechs, Financial Advisers, Medical Services And The Twitch Of China
For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud. The IPO dates below are expected but not ... Read More
from Benzinga
Fulcrum Therapeutics IPO: What You Need To Know
The week's IPO slate consists of a handful of biotechs, and among them is a clinical-stage biotech company focused on genetic ... Read More
from Benzinga
AssetMark Financial Holdings IPO: What You Need To Know
A technology provider to wealth management firms is among the companies testing the waters in the public markets this week. The ... Read More
from Benzinga
The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings
Last week was a quiet one for the biotech space with the exception ofa few clinical trial readouts. Pharma and biotech stocks ... Read More
from Benzinga
Sunnova Energy IPO: What You Need To Know
A service provider that facilitates the usage of cheaply available solar energy – a non-conventional source of energy – by ... Read More
from Benzinga
Mirum Pharmaceuticals IPO: What You Need To Know
A late-stage biotech, which was spun-off from Shire, is testing the IPO market. The IPO Terms Foster City, California-based Mirum ... Read More
from Benzinga
How To Invest In Pre-IPO Startups
This year has brought a flurry of high-profile IPOs, but the new stocks have hit the market with mixed returns for early investors. ... Read More
from Benzinga
DouYu International IPO: What You Need To Know
DouYu International (NASDAQ: DOYU) has filed for offering 67.387 million American Depository Shares, representing 6.739 million ordinary ... Read More
from Benzinga
Big Bank Results Seen Strong As Executives Manage Through Challenges
In many ways, things still seem stacked against big banks as earnings season approaches. Mortgage rates continue to fall and the ... Read More
from Benzinga
IPO mania produced record exits for VCs in second quarter, PitchBook says
Uber accounted for almost half of the exit value from venture-backed companies in the quarter, while Slack, Zoom, Pinterest and CrowdStrike made up most of the rest. Read More
from CNBC.com News
The 2019 IPOs will have a correction 'sooner or later,' Jim Cramer warns
Jim Cramer breaks down how investors "can view the sell-off as a buying opportunity, not a calamity." Read More
from CNBC.com News
Reports: McAfee Considering IPO
Cybersecurity company McAfee is considering going public later this year or next, according to media reports. The company, currently ... Read More
from Benzinga
Buyer beware: Endeavor IPO offers up a company with huge debt, volatile earnings, says Bernstein
Investors eyeing the initial public offering of entertainment giant Endeavor Group Holdings Inc. need a strong stomach, as they will be buying into a company with high debt levels and unpredictable and... Read More
from MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.